VPIM
RAPT

Vanguard Personalized Indexing Management’s RAPT Therapeutics RAPT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,661
Closed -$35.7K – 2021
2025
Q1 		$35.7K Sell
3,661
-46
-1% -$452 ﹤0.01% 1708
2024
Q4 		$46.9K Buy
+3,707
New +$47.1K ﹤0.01% 1702

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Vanguard Personalized Indexing Management's RAPT Position: Q2 2025 in Review

Vanguard Personalized Indexing Management sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 3,661 shares — an estimated $35.7K sold.

Vanguard Personalized Indexing Management first reported a position in RAPT in Q4 2024 and held it in 2 quarters. The position peaked at $46.9K in Q4 2024. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Vanguard Personalized Indexing Management reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 3,661 RAPT Therapeutics shares in Q2 2025, an estimated $35.7K.
  • Vanguard Personalized Indexing Management first reported a position in RAPT Therapeutics in Q4 2024 and held it in 2 quarters.
  • Vanguard Personalized Indexing Management's RAPT Therapeutics position peaked at $46.9K in Q4 2024.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2025, filed 25 Jul 2025.